| Bioactivity | CXCR7 antagonist-1 hydrochloride is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 hydrochloride is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases (extracted from patent WO2014085490A1, compound 1.128)[1]. |
| Name | CXCR7 antagonist-1 hydrochloride |
| Formula | C21H20ClFN6O |
| Molar Mass | 426.87 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Junfa Fan, et al. Cxcr7 antagonists. Patent WO2014085490A1. |
CXCR7 antagonist-1 hydrochloride
CAS: F: C21H20ClFN6O W: 426.87
CXCR7 antagonist-1 hydrochloride is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as t
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.